Structures by: Muthiah P. T.
Total: 118
C20H24Cu2N4O16P4
C20H24Cu2N4O16P4
Chemistry Central Journal (2014) 8, 1 42
a=19.1486(9)Å b=8.1694(3)Å c=19.1208(8)Å
α=90.00° β=102.385(4)° γ=90.00°
C17H12ClCuN3O8S,H2O
C17H12ClCuN3O8S,H2O
Chemistry Central Journal (2014) 8, 1 42
a=8.6712(3)Å b=10.3617(4)Å c=12.2860(4)Å
α=95.336(2)° β=96.851(2)° γ=107.630(2)°
C20H14Cl2CuN2O5S2
C20H14Cl2CuN2O5S2
Chemistry Central Journal (2014) 8, 1 42
a=23.8658(4)Å b=16.6525(4)Å c=11.3381(2)Å
α=90.00° β=99.9940(10)° γ=90.00°
C25H18ClCuN4O2S,ClO4
C25H18ClCuN4O2S,ClO4
Chemistry Central Journal (2014) 8, 1 42
a=14.9443(2)Å b=15.1728(2)Å c=15.3055(2)Å
α=111.9480(10)° β=116.6730(10)° γ=97.6060(10)°
C22H14Cl2CuN2O5S2
C22H14Cl2CuN2O5S2
Chemistry Central Journal (2014) 8, 1 42
a=13.4364(3)Å b=10.4855(3)Å c=20.0390(4)Å
α=90.00° β=123.7410(10)° γ=90.00°
C20H18N2O2S
C20H18N2O2S
RSC Advances (2013) 3, 42 19300
a=8.337(5)Å b=8.480(5)Å c=12.878(5)Å
α=99.234(5)° β=106.409(5)° γ=93.053(5)°
C19H16N2O2S
C19H16N2O2S
RSC Advances (2013) 3, 42 19300
a=16.8526(2)Å b=9.00520(10)Å c=27.1364(4)Å
α=90.00° β=125.2820(10)° γ=90.00°
'Ni hydrozone complex'
C32H25N2NiO2P
RSC Advances (2012) 2, 32 12190
a=14.6153(2)Å b=10.18390(10)Å c=17.6301(2)Å
α=90.00° β=93.0130(10)° γ=90.00°
C128H111.2Co3N8O17.6P4
C128H111.2Co3N8O17.6P4
RSC Advances (2012) 2, 32 12190
a=10.5181(5)Å b=14.2200(6)Å c=19.9005(9)Å
α=77.689(3)° β=84.636(3)° γ=79.795(3)°
C14H19N4O3,C7H4ClO2,1.2(H2O)
C14H19N4O3,C7H4ClO2,1.2(H2O)
CrystEngComm (2003) 5, 9 48
a=7.2710(10)Å b=9.144(2)Å c=16.674(3)Å
α=86.93(3)° β=80.92(3)° γ=85.43(3)°
C14H19N4O3,C7H4O2Cl
C14H19N4O3,C7H4O2Cl
CrystEngComm (2003) 5, 9 48
a=6.545(10)Å b=28.280(6)Å c=11.633(2)Å
α=90.000(3)° β=103.37(3)° γ=90.000(3)°
Trimethoprim p-toluenesulfonate
C21H26N4O6S
CrystEngComm (2003) 5, 15 70
a=13.407(3)Å b=10.039(3)Å c=17.115(7)Å
α=90.00° β=90.60(3)° γ=90.00°
Trimethoprim sulfanilate monohydrate
C20H27N5O7S
CrystEngComm (2003) 5, 15 70
a=17.855(4)Å b=6.136(10)Å c=21.349(4)Å
α=90.00° β=109.080(3)° γ=90.00°
(2,4-diamino-5-(3',4',5'-trimethoxybenzyl)pyrimidinium) benzenesulfonate, monohydrate.
(C14H19N4O3),(C6H5SO3).H20
CrystEngComm (2003) 5, 15 70
a=17.507(2)Å b=6.323(3)Å c=21.350(2)Å
α=90.00° β=107.80(2)° γ=90.00°
2,4-diamino-5-(3',4',5'-trimethoxybenzyl)pyrimidinium 3- carboxy-4-hydroxybenzene sulfonate dihydrate
C14H19N4O3,C7H5O6S,2H2O
CrystEngComm (2003) 5, 15 70
a=11.442(2)Å b=18.769(3)Å c=12.783(3)Å
α=90.00° β=114.18(3)° γ=90.00°
Benzthiazide-monohydrate
C15H16Cl1N3O5S3
CrystEngComm (2003) 5, 86 487
a=12.243(2)Å b=4.905(2)Å c=31.957(3)Å
α=90.00° β=96.34(3)° γ=90.00°
Benzthiazide-anhydrate
C15H14Cl1N3O4S3
CrystEngComm (2003) 5, 86 487
a=10.726(2)Å b=9.0275(13)Å c=18.333(7)Å
α=90.00° β=97.24(2)° γ=90.00°
4-Amino-5-chloro-2,6-dimethylpyridin-1-ium 5-chloro-2-hydroxybenzoate
C6H9ClN3,C7H4ClO3
Acta Crystallographica Section C (2017) 73, 11 862-868
a=24.7483(12)Å b=6.9525(3)Å c=18.1423(8)Å
α=90° β=111.500(3)° γ=90°
6-Amino-5-chloro-2,4-dimethylpyridin-1-ium 5-chloro-2-hydroxybenzoate
C6H9ClN3,C7H4ClO3
Acta Crystallographica Section C (2017) 73, 11 862-868
a=9.3874(4)Å b=10.5102(4)Å c=15.4295(6)Å
α=71.1670(10)° β=83.335(2)° γ=87.7300(10)°
2-Amino-4,6-dimethoxypyrimidin-1ium thiophene-2-carboxylate
C6H10N3O2,C5H3O2S
Acta Crystallographica Section C (2017) 73, 11 862-868
a=6.7335(3)Å b=7.6307(4)Å c=25.0638(10)Å
α=90° β=93.928(4)° γ=90°
4-Amino-5-chloro-2,6-dimethylpyrimidine--3-bromothiophene-2-carboxylic acid (1/1)
C5H3BrO2S,C6H8ClN3
Acta Crystallographica Section C (2018) 74, 9
a=7.5237(4)Å b=7.5739(4)Å c=12.5089(7)Å
α=79.629(2)° β=79.596(2)° γ=75.895(2)°
4-Amino-5-chloro-2,6-dimethylpyrimidine--5-chlorothiophene-2-carboxylic acid (1/1)
C6H8ClN3,C5H3ClO2S
Acta Crystallographica Section C (2018) 74, 9
a=7.2182(3)Å b=7.6364(3)Å c=12.7516(6)Å
α=90.707(2)° β=102.629(2)° γ=105.338(2)°
4-Amino-5-chloro-2,6-dimethylpyrimidine---2,4-dichlorobenzoic acid (1/1)
C6H8ClN3,C7H4Cl2O2
Acta Crystallographica Section C (2018) 74, 9
a=7.3015(4)Å b=7.5060(6)Å c=14.9665(8)Å
α=92.539(5)° β=98.522(5)° γ=113.657(7)°
4-Amino-5-chloro-2,6-dimethylpyrimidine--5-methylthiophene-2-carboxylic acid (1/1)
C6H8ClN3,C6H6O2S
Acta Crystallographica Section C (2018) 74, 9
a=8.273(3)Å b=12.746(4)Å c=13.320(4)Å
α=90° β=102.390(5)° γ=90°
4-Amino-5-chloro-2,6-dimethylpyrimidine--2-aminobenzoic acid (1/1)
C6H8ClN3,C7H7NO2
Acta Crystallographica Section C (2018) 74, 9
a=8.0965(2)Å b=7.2427(3)Å c=24.0738(9)Å
α=90° β=90.831(3)° γ=90°
4-Amino-5-chloro-2,6-dimethylpyrimidine--benzoic acid (1/1)
C6H8ClN3,C7H6O2
Acta Crystallographica Section C (2018) 74, 9
a=10.1421(5)Å b=10.4218(5)Å c=13.2681(6)Å
α=90° β=107.804(5)° γ=90°
4-Amino-5-chloro-2,6-dimethylpyrimidine--4-methylbenzoic acid (1/1)
C6H8ClN3,C8H8O2
Acta Crystallographica Section C (2018) 74, 9
a=8.0223(5)Å b=13.6901(10)Å c=13.3346(10)Å
α=90° β=101.557(7)° γ=90°
4-Amino-5-chloro-2,6-dimethylpyrimidine--2-methylbenzoic acid (1/1)
C6H8ClN3,C8H8O2
Acta Crystallographica Section C (2018) 74, 9
a=7.3992(2)Å b=13.9842(4)Å c=26.9897(8)Å
α=90° β=90° γ=90°
4-Amino-5-chloro-2,6-dimethylpyrimidine--3-methylbenzoic acid (1/1)
C6H8ClN3,C8H8O2
Acta Crystallographica Section C (2018) 74, 9
a=8.45240(10)Å b=13.5387(2)Å c=24.9813(3)Å
α=90° β=90° γ=90°
4-Amino-5-chloro-2,6-dimethylpyrimidine--4-aminobenzoic acid (1/1)
C6H8ClN3,C7H7NO2
Acta Crystallographica Section C (2018) 74, 9
a=7.8899(2)Å b=13.2361(3)Å c=13.3212(3)Å
α=90° β=101.254(2)° γ=90°
5-Fluorouracil--4-methylbenzoic acid (1/1)
C8H8O2,C4H3FN2O2
Acta Crystallographica Section C (2017) 73, 3 259-263
a=13.6345(15)Å b=6.9015(7)Å c=12.6905(14)Å
α=90° β=105.429(4)° γ=90°
5-Fluorouracil--3-nitrobenzoic acid (1/1)
C7H5NO4,C4H3FN2O2
Acta Crystallographica Section C (2017) 73, 3 259-263
a=5.9011(12)Å b=9.795(2)Å c=11.674(2)Å
α=110.76(3)° β=91.84(3)° γ=99.59(3)°
2-{[(2-Chlorophenyl)imino]methyl}phenol
C13H10ClNO
Acta Crystallographica Section E (2015) 71, 1 o48
a=6.8591(2)Å b=12.1829(4)Å c=13.5405(5)Å
α=90° β=90° γ=90°
4-[(5-methylisoxazol-3-yl)aminosulfonyl]anilinium 3,5-dinitrosalicylate
C10H12N3O3S,C7H3N2O7
Acta Crystallographica Section E (2015) 71, 6 618-620
a=8.55510(10)Å b=10.5000(2)Å c=12.7576(3)Å
α=106.4630(10)° β=100.9130(10)° γ=108.2720(10)°
2-Amino-4,6-dimethoxypyrimidinium thiophene-2-carboxylate
C6H10N3O2,C5H3O2S
Acta Crystallographica Section E (2015) 71, 7 o479-o480
a=6.7335(3)Å b=7.6307(4)Å c=25.0638(10)Å
α=90° β=93.928(4)° γ=90°
Tetraammine(carbonato-κ^2^<i>O</i>,<i>O</i>)cobalt(III) perchlorate
CH12CoN4O3,ClO4
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 8 i45-i46
a=17.8961(5)Å b=8.0768(2)Å c=6.8871(2)Å
α=90° β=90° γ=90°
2-Amino-4,6-dimethylpyrimidine--sorbic acid (1/1)
C6H9N3,C6H8O2
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 8 o1235
a=7.8441(6)Å b=9.9413(8)Å c=10.2846(13)Å
α=112.058(7)° β=98.333(8)° γ=111.306(5)°
Tetrakis(μ~2~-4-hydroxybenzoato-κ^2^<i>O</i>:<i>O</i>)bis[aquacopper(II)] dimethylformamide disolvate dihydrate
C28H24Cu2O14,2(C3H7NO),2(H2O)
Acta crystallographica. Section C, Crystal structure communications (2013) 69, Pt 12 1498-1502
a=9.6946(2)Å b=10.4874(2)Å c=10.6819(2)Å
α=82.4580(10)° β=66.9510(10)° γ=81.9040(10)°
Tetrakis(μ-4-methoxybenzoato-κ^2^<i>O</i>:<i>O</i>)bis[(dimethylformamide-κ<i>O</i>)copper(II)]
C38H42Cu2N2O14
Acta crystallographica. Section C, Crystal structure communications (2013) 69, Pt 12 1498-1502
a=12.2001(2)Å b=18.1548(4)Å c=9.2514(2)Å
α=90° β=101.0420(10)° γ=90°
4-Amino-5-fluoro-1,2-dihydropyrimidin-2-one--1,3,5-triazine-2,4,6-triamine (4/1)
4(C4H4FN3O),C3H6N6
Acta crystallographica. Section E, Crystallographic communications (2016) 72, Pt 4 552-555
a=18.343(4)Å b=7.9591(16)Å c=19.680(4)Å
α=90° β=114.65(3)° γ=90°
2-Aminopyridinium 6-chloronicotinate
C5H7N2,C6H3ClNO2
Acta crystallographica. Section E, Crystallographic communications (2015) 71, Pt 9 o655-6
a=8.6844(4)Å b=10.8112(5)Å c=11.9235(6)Å
α=90° β=95.2046(9)° γ=90°
3-Acetoxy-2-methylbenzoic acid
C10H10O4
Acta crystallographica. Section E, Crystallographic communications (2015) 71, Pt 7 o474
a=7.754(2)Å b=11.346(3)Å c=21.187(6)Å
α=90° β=90° γ=90°
5-fluorocytosinium salicylate
C4H5FN3O1,C7H5O31
Acta Crystallographica Section E (2001) 57, 10 o933-o936
a=13.509(5)Å b=10.519(3)Å c=8.099(2)Å
α=90° β=101.540(15)° γ=90°
2-amino-4,6-dimethylpyrimidinium bromide 2-amino-4,6-dimethylpyrimidine monohydrate
C6H10N3,Br,C6H9N3,H2O
Acta Crystallographica Section E (2004) 60, 5 o747-o749
a=7.002(4)Å b=9.438(8)Å c=12.658(6)Å
α=79.56(5)° β=83.85(4)° γ=82.98(6)°
Strontium ferron trihydrate
C18H14I2N2O10S2Sr,H2O
Acta Crystallographica Section E (2004) 60, 11 m1576-m1579
a=20.539(3)Å b=7.012(2)Å c=19.243(3)Å
α=90° β=116.95(3)° γ=90°
Ferron
C9H6INO4S
Acta Crystallographica Section C (1996) 52, 8 2072-2073
a=9.5704(9)Å b=13.364(2)Å c=8.748(2)Å
α=90° β=108.83(1)° γ=90°
2-amino-4,6-dimethoxy pyrimidin-1-ium thiobarbiturate dihydrate
C6H10N3O2,C4H3N2O2S,1.75(H2O)
Acta Crystallographica Section B Structural Science, Crystal Engineering and Materials (2015) 71, 2
a=10.2941(5)Å b=10.9564(4)Å c=14.3656(6)Å
α=77.876(2)° β=86.712(3)° γ=75.243(2)°
2-amino-4,6-dimethyl pyrimidin-1-ium thiobarbiturate trihydrate
C4H3N2O2S,C6H10N3,3(H2O)
Acta Crystallographica Section B Structural Science, Crystal Engineering and Materials (2015) 71, 2
a=12.0229(2)Å b=12.1092(3)Å c=13.2095(2)Å
α=98.9210(10)° β=115.4030(10)° γ=108.2410(10)°
2,4-diamino-5-(3,4,5-trimethoxybenzyl) pyrimidine thiobarbiturate
C14H19N4O3,C4H3N2O2S
Acta Crystallographica Section B Structural Science, Crystal Engineering and Materials (2015) 71, 2
a=7.83290(10)Å b=15.2433(2)Å c=17.7173(2)Å
α=90.00° β=101.9250(10)° γ=90.00°
Hemi(4,4'-bipyridinium) tris(5-chlorothiophene-2-carboxylato)dioxidouranate(VI) monohydrate
C10H10N22,2(C15H6Cl3O8S3U),2(H2O)
Acta Crystallographica Section C (2011) 67, 3 m69-m72
a=14.1630(5)Å b=17.5777(6)Å c=11.2915(4)Å
α=90.00° β=104.595(2)° γ=90.00°
Hemi[4,4'-(ethane-1,2-diyl)dipyridinium]tris(5-chlorothiophene-2-carboxylato)dioxidouranate(VI) monohydrate
C12H14N22,2(C15H6Cl3O8S3U),2(H2O)
Acta Crystallographica Section C (2011) 67, 3 m69-m72
a=14.5189(2)Å b=18.1169(3)Å c=11.1399(2)Å
α=90.00° β=97.1230(10)° γ=90.00°
Benzyladeninium p-toluene sulfonate
C12H12N5,C7H7O3S
Acta Crystallographica Section C (2011) 67, 5 o192-o194
a=9.5741(10)Å b=9.9089(11)Å c=11.3324(12)Å
α=99.957(6)° β=90.886(7)° γ=116.562(6)°
Trimethorprim formate
C14H19N4O3,CHO2
Acta Crystallographica Section C (2002) 58, 8 o510-o512
a=17.555(2)Å b=11.708(2)Å c=16.696(8)Å
α=90° β=92.43(3)° γ=90°
N^6^-furfuryladenine hydrochloride
C10H10N5O,Cl
Acta Crystallographica Section C (2003) 59, 1 o27-o29
a=4.5610(8)Å b=8.8980(17)Å c=13.562(3)Å
α=90° β=92.138(5)° γ=90°
Pyrimethaminium 4-methylbenzoate
C12H14ClN4,C8H7O2
Acta Crystallographica Section C (2010) 66, 3 o104-o108
a=17.1373(3)Å b=16.4776(3)Å c=16.6127(3)Å
α=90° β=119.0800(10)° γ=90°
Pyrimethaminium 2,4-dichlorobenzoate
C12H14ClN4,C7H3Cl2O2
Acta Crystallographica Section C (2010) 66, 3 o104-o108
a=14.3808(2)Å b=12.6799(2)Å c=22.4021(3)Å
α=90° β=90° γ=90°
Pyrimethaminium 3-hydroxypicolinate
C12H14ClN4,C6H4NO3
Acta Crystallographica Section C (2010) 66, 3 o104-o108
a=11.2563(3)Å b=14.3968(4)Å c=11.7902(3)Å
α=90° β=103.6250(10)° γ=90°
Triaqua(μ-7-iodo-8-oxidoquinoline-5-sulfonato-κ^2^<i>N</i>,<i>O</i>^5^)dioxidouranium(VI) dihydrate
C9H10INO9SU,2(H2O)
Acta Crystallographica Section C (2010) 66, 2 m48-m50
a=8.3742(2)Å b=10.1785(2)Å c=11.6146(2)Å
α=74.9580(10)° β=84.7170(10)° γ=66.7010(10)°
Acetoguanaminium hydrogen phthalate
C4H8N5,C8H5O4
Acta Crystallographica Section C (2010) 66, 7 o324-o328
a=7.0743(2)Å b=23.4468(5)Å c=8.11340(10)Å
α=90° β=107.0630(10)° γ=90°
Acetoguanaminium hydrogen maleate
C4H8N5,C4H3O4
Acta Crystallographica Section C (2010) 66, 7 o324-o328
a=7.1921(3)Å b=8.2359(3)Å c=9.4775(4)Å
α=98.287(2)° β=104.656(2)° γ=91.032(3)°
Acetoguanaminium 3-hydroxypicolinate monohydrate
C4H8N5,C6H4NO3,H2O
Acta Crystallographica Section C (2010) 66, 7 o324-o328
a=7.0397(16)Å b=24.680(5)Å c=7.5047(19)Å
α=90° β=94.462(7)° γ=90°
2-amino-4,6-dimethoxypyrimidinium picrate
C6H10N3O2,C6H2N3O7
Acta Crystallographica Section C (2009) 65, 2 o42-o45
a=8.8796(2)Å b=13.2847(3)Å c=14.1395(3)Å
α=99.8200(10)° β=100.7010(10)° γ=105.0950(10)°
Pyrimethaminium picrate dimethyl sulfoxide solvate
C12H14ClN4,C6H2N3O7,C2H6OS
Acta Crystallographica Section C (2009) 65, 2 o42-o45
a=9.3365(3)Å b=11.1245(3)Å c=13.1861(6)Å
α=83.779(3)° β=86.057(3)° γ=65.784(3)°
4,6-Dimethoxypyrimidin-2-amine--2-(1<i>H</i>-indol-3-yl)acetic acid (1/1)
C10H9NO2,C6H9N3O2
Acta Crystallographica Section E (2010) 66, 10 o2634-o2635
a=7.45550(10)Å b=10.7197(2)Å c=11.2537(2)Å
α=62.9810(10)° β=85.8630(10)° γ=85.5840(10)°
Dibromobis(cytosine)zinc(II)'
C8H10Br2N6O2Zn
Acta Crystallographica Section E (2010) 66, 12 m1693
a=7.1337(2)Å b=7.8375(2)Å c=12.4275(3)Å
α=86.746(2)° β=75.199(2)° γ=87.448(2)°
2-Methoxyanilinium 3-hydroxy-2,4,6-trinitrophenolate
C7H10NO,C6H2N3O8
Acta Crystallographica Section E (2011) 67, 3 o686
a=10.6957(4)Å b=17.8368(5)Å c=8.0527(3)Å
α=90° β=91.991(2)° γ=90°
2-amino-4,6-dimethylpyrimidine-anthranilic acid
C6H9N3,C7H7NO2
Acta Crystallographica Section E (2010) 66, 3 o516
a=7.1922(2)Å b=7.4269(2)Å c=13.0675(3)Å
α=77.5830(10)° β=78.9900(10)° γ=82.4730(10)°
4-[(2-Hydroxybenzylidene)amino]-<i>N</i>-(5-methylisoxazol-3-yl)benzenesulfonamide
C17H15N3O4S
Acta Crystallographica Section E (2010) 66, 10 o2574
a=7.03740(10)Å b=17.9244(3)Å c=14.5175(3)Å
α=90° β=112.9620(10)° γ=90°
2,4-diamino-6-methyl-1,3,5-triazin-1-ium tetrafluoroborate
C4H8N5,BF4
Acta Crystallographica Section E (2011) 67, 10 o2762
a=6.9982(3)Å b=8.2887(4)Å c=8.5353(4)Å
α=63.931(2)° β=83.209(3)° γ=85.057(3)°
2-Amino-4,6-dimethoxypyrimidin-1-ium <i>p</i>-toluenesulfonate
C6H10N3O2,C7H7O3S
Acta Crystallographica Section E (2011) 67, 10 o2679-o2680
a=15.2116(2)Å b=12.1422(2)Å c=8.34970(10)Å
α=90° β=90° γ=90°
2,6,6-trimethylcyclohexene-1-carbaldehyde oxime
C10H17NO
Acta Crystallographica Section E (2011) 67, 10 o2732
a=7.5670(3)Å b=7.7208(3)Å c=9.3072(4)Å
α=81.212(3)° β=76.590(3)° γ=71.385(3)°
2-Amino-4,6-dimethylpyrimidin-1-ium 2,3,5-triiodobenzoate 2,3,5-triiodobenzoic acid monosolvate
C6H10N3,C7H3I3O2,C7H2I3O2
Acta Crystallographica Section E (2011) 67, 12 o3241-o3242
a=9.4654(2)Å b=9.6683(2)Å c=31.1553(5)Å
α=90° β=90.3660(10)° γ=90°
<i>N</i>'-Hydroxypyrimidine-2-carboximidamide
C5H6N4O
Acta Crystallographica Section E (2014) 70, 10 o1107-o1108
a=7.4066(7)Å b=8.0165(8)Å c=10.2200(9)Å
α=90.00° β=101.888(6)° γ=90.00°
2-amino-4,6-dimethylpyrimidine-2-methylbenzoic acid
C8H8O2,C6H9N3
Crystal Growth & Design (2011) 11, 8 3579
a=24.7397(2)Å b=7.51230(10)Å c=14.9760(2)Å
α=90.00° β=90.9490(10)° γ=90.00°
2-amino-4,6-dimethylpyrimidine-3-methylbenzoic acid
C8H8O2,C6H9N3
Crystal Growth & Design (2011) 11, 8 3579
a=26.9424(12)Å b=7.3192(3)Å c=14.3603(6)Å
α=90.00° β=92.473(4)° γ=90.00°
2-amino-4-chloro-6-methylpyrimidine-4-chlorobenzoic acid
C5H6ClN3,C7H5ClO2
Crystal Growth & Design (2011) 11, 8 3579
a=26.6684(4)Å b=7.37620(10)Å c=14.2490(2)Å
α=90.00° β=99.869(2)° γ=90.00°
2-amino-4-chloro-6-methylpyrimidine-benzoic acid
C5H6ClN3,C7H6O2
Crystal Growth & Design (2011) 11, 8 3579
a=7.5335(13)Å b=8.1173(12)Å c=21.321(2)Å
α=90.00° β=103.213(6)° γ=90.00°
2-amino-4-chloro-6-methylpyrimidine-3-methylbenzoic acid
C8H8O2,C5H6ClN3
Crystal Growth & Design (2011) 11, 8 3579
a=7.526(5)Å b=8.809(5)Å c=21.362(5)Å
α=90.00° β=102.732(15)° γ=90.00°
2-amino-4,6-dimethylpyrimidine-2-chlorobenzoic acid
C6H9N3,C7H5ClO2
Crystal Growth & Design (2011) 11, 8 3579
a=7.85100(10)Å b=24.1910(4)Å c=8.31160(10)Å
α=90.00° β=120.5910(10)° γ=90.00°
2-amino-4-chloro-6-methylpyrimidine-2-chlorobenzoic acid
C5H6ClN3,C7H5ClO2
Crystal Growth & Design (2011) 11, 8 3579
a=7.7594(3)Å b=24.3335(7)Å c=8.2817(3)Å
α=90.00° β=120.610(3)° γ=90.00°
2-amino-4-chloro-6-methylpyrimidine-2-methylbenzoic acid
C8H8O2,C5H6ClN3
Crystal Growth & Design (2011) 11, 8 3579
a=7.91180(10)Å b=24.0539(4)Å c=8.21120(10)Å
α=90.00° β=119.9260(10)° γ=90.00°
2-amino-4-chloro-6-methylpyrimidinecinnamic acid
C9H8O2,C5H6ClN3
Crystal Growth & Design (2011) 11, 8 3579
a=6.0521(12)Å b=7.9650(16)Å c=30.415(5)Å
α=90.00° β=97.137(11)° γ=90.00°
2-amino-4-chloro-6-methylpyrimidine-anisic acid
C8H8O3,C5H6ClN3
Crystal Growth & Design (2011) 11, 8 3579
a=7.54990(10)Å b=8.92210(10)Å c=11.1715(2)Å
α=104.4000(10)° β=99.6320(10)° γ=94.9090(10)°
2-amino-4,6-dimethylpyrimidine-cinnamic acid (1/2)
2(C9H8O2),C6H9N3
Crystal Growth & Design (2011) 11, 8 3579
a=8.68110(10)Å b=11.5513(2)Å c=11.5896(2)Å
α=87.2270(10)° β=77.1660(10)° γ=81.8340(10)°
2-amino-4,6-dimethylpyrimidine-4-nitrobenzoic acid
C6H9N3,C7H5NO4
Crystal Growth & Design (2011) 11, 8 3579
a=6.8705(12)Å b=7.4812(14)Å c=13.716(2)Å
α=81.763(9)° β=80.563(9)° γ=84.009(9)°
2-amino-4-chloro-6-methylpyrimidine-4-nitrobenzoic acid
C7H5NO4,C5H6ClN3
Crystal Growth & Design (2011) 11, 8 3579
a=6.9797(4)Å b=7.3469(4)Å c=13.7131(7)Å
α=80.291(3)° β=78.448(3)° γ=85.491(3)°
2-amino-4,6-dimethylpyrimidine-3-nitrobenzoic acid
C6H9N3,C7H5NO4
Crystal Growth & Design (2011) 11, 8 3579
a=6.96510(10)Å b=7.5279(2)Å c=13.2985(3)Å
α=94.2540(10)° β=92.7510(10)° γ=98.4820(10)°
2-amino-4-chloro-6-methylpyrimidinephthalic acid
C5H6ClN3,C8H6O4
Crystal Growth & Design (2011) 11, 8 3579
a=11.1623(5)Å b=7.4613(3)Å c=17.0269(8)Å
α=90.00° β=93.404(3)° γ=90.00°
2-amino-4-chloro-6-methylpyrimidine-3-nitrobenzoic acid
C7H5NO4,C5H6ClN3
Crystal Growth & Design (2011) 11, 8 3579
a=9.8924(3)Å b=15.0036(4)Å c=11.3404(4)Å
α=90.00° β=121.196(2)° γ=90.00°
2-amino-4,6-dimethoxypyrimidine-2-chlorobenzoic acid
C6H9N3O2,C7H5ClO2
Crystal Growth & Design (2012) 12, 7 3766
a=7.7162(3)Å b=7.9195(3)Å c=12.2788(5)Å
α=86.575(3)° β=86.801(2)° γ=71.148(2)°
2-amino-4,6-dimethoxypyrimidine-2-methylbenzoic acid
C6H9N3O2,C8H8O2
Crystal Growth & Design (2012) 12, 7 3766
a=7.5478(2)Å b=7.8842(2)Å c=13.4987(3)Å
α=88.995(2)° β=75.052(2)° γ=73.045(2)°
2-amino-4,6-dimethoxypyrimidine-cinnamic acid
C6H9N3O2,C9H8O2
Crystal Growth & Design (2012) 12, 7 3766
a=4.99690(10)Å b=11.1131(2)Å c=14.0377(3)Å
α=93.866(2)° β=92.245(2)° γ=97.287(2)°
2-amino-4,6-dimethoxypyrimidine-4-methoxybenzoic acid
C6H9N3O2,C8H8O3
Crystal Growth & Design (2012) 12, 7 3766
a=7.02950(10)Å b=26.2951(4)Å c=8.53710(10)Å
α=90.00° β=106.8150(10)° γ=90.00°
2-amino-4,6-dimethoxypyrimidine-Isophthalic acid
2(C6H9N3O2),C8H6O4
Crystal Growth & Design (2012) 12, 7 3766
a=9.4556(2)Å b=11.1124(3)Å c=11.8799(3)Å
α=83.595(2)° β=74.5320(10)° γ=66.940(2)°
2-amino-4,6-dimethoxypyrimidine-4-nitrobenzoic acid
C6H9N3O2,C7H5NO4
Crystal Growth & Design (2012) 12, 7 3766
a=4.76200(10)Å b=10.9490(2)Å c=28.4995(6)Å
α=90.00° β=90.455(2)° γ=90.00°
2-amino-4,6-dimethoxypyrimidine-chloroacetic acid
C6H9N3O2,C2H3ClO2
Crystal Growth & Design (2012) 12, 7 3766
a=12.6481(2)Å b=4.03740(10)Å c=21.2104(4)Å
α=90.00° β=91.7390(10)° γ=90.00°
2-amino-4,6-dimethylpyrimidine-glutaric acid
2(C6H9N3),C5H8O4
Crystal Growth & Design (2012) 12, 7 3766
a=29.6875(11)Å b=4.6937(2)Å c=14.2292(6)Å
α=90.00° β=90.00° γ=90.00°
2-amino-4,6-dimethylpyrimidine-adipic acid
C6H10O4,2(C6H9N3)
Crystal Growth & Design (2012) 12, 7 3766
a=8.2625(3)Å b=17.4876(5)Å c=14.3439(5)Å
α=90.00° β=93.532(2)° γ=90.00°
2-amino-4,6-dimethoxypyrimidine-trichloroacetic acid
C6H10N3O2,C2Cl3O2
Crystal Growth & Design (2012) 12, 7 3766
a=12.2675(2)Å b=15.2303(2)Å c=7.12170(10)Å
α=90.00° β=97.7280(10)° γ=90.00°
2-amino-4,6-dimethoxypyrimidine-5-chlorosalicylic acid
C6H10N3O2,C7H4ClO3
Crystal Growth & Design (2012) 12, 7 3766
a=14.4255(2)Å b=11.6661(2)Å c=17.4006(2)Å
α=90.00° β=90.00° γ=90.00°